Tuberculosis - Foundations and Global Epidemiology

Tuberculosis: Overview and Epidemiology What is Tuberculosis? Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. It's important to understand that TB infection exists in two distinct forms: latent TB infection and active TB disease. Most people infected with TB develop the latent form, where the bacteria remain dormant in the body without causing symptoms or spreading to others. However, approximately 10% of people with latent TB will eventually progress to active disease, which is fatal in roughly half of untreated cases. Active TB is contagious and requires prompt treatment. Where Does TB Affect the Body? TB most commonly affects the lungs, a condition called pulmonary tuberculosis. However, Mycobacterium tuberculosis can spread throughout the body and cause extrapulmonary tuberculosis, which affects organs such as the lymph nodes, bones, kidneys, and meninges. The image below shows common symptoms and manifestations of TB infection: When TB affects the lungs, patients typically develop a productive cough (often with blood-tinged sputum), night sweats, fever, and weight loss. These respiratory symptoms are the hallmark of pulmonary TB. When TB spreads to other organs, symptoms depend on the specific organs involved—for example, TB meningitis affects the nervous system, while TB lymphadenitis causes enlarged lymph nodes. The Global Burden of TB TB remains one of the leading causes of death from a single infectious disease worldwide. To appreciate the scale of this public health challenge, consider these key facts: Approximately one-quarter of the world's population has been infected with Mycobacterium tuberculosis at some point New infections occur in about 1% of the global population each year Despite these enormous numbers, 90-95% of infected individuals remain asymptomatic because they have latent TB rather than active disease <extrainfo> In 2022, an estimated 10.6 million people developed active tuberculosis globally, causing 1.3 million deaths. These numbers fluctuate year to year, but TB consistently ranks as the second leading cause of death from an infectious disease worldwide (after COVID-19). </extrainfo> The burden of TB is not evenly distributed globally. High-burden countries, particularly in sub-Saharan Africa and South Asia, contribute disproportionately to global TB cases. This geographic concentration reflects a combination of factors including poverty, malnutrition, overcrowding, weak health systems, and high rates of HIV co-infection. Why TB Remains a Challenge Several interconnected factors explain why TB continues to be a major public health problem despite the availability of effective treatments: Economic and Health System Factors: TB imposes substantial economic costs on health systems due to prolonged treatment (typically 6 months), hospitalizations, and loss of productivity from affected individuals. In many high-burden countries, limited resources mean diagnostic delays, incomplete treatment courses, and inadequate treatment monitoring—all of which allow TB to continue spreading. Co-infection with Other Diseases: TB frequently coexists with HIV, which severely weakens the immune system and allows TB to progress more rapidly and be harder to treat. TB also worsens outcomes in people with chronic obstructive pulmonary disease and tuberculosis. The combination of multiple diseases creates greater health burden than any single disease alone. Social and Stigma Factors: TB carries significant social stigma. Fear of contagion and concerns about social exclusion often cause people to delay seeking diagnosis and treatment. These social barriers—shaped by cultural beliefs, historical perceptions, and misconceptions about TB—can be as much an obstacle to disease control as the biological factors. <extrainfo> Trends and Additional Epidemiological Details Historical data shows some encouraging progress: total TB case numbers have declined since 2005, and new case notifications have fallen since 2002. The case-fatality rate dropped from 8% in 1995 to 4% in 2008, reflecting improvements in diagnosis and treatment. For untreated smear-positive pulmonary tuberculosis (in people without HIV), the natural history shows that 50-60% die within five years, while 20-25% achieve spontaneous cure. This underscores the critical importance of early diagnosis and treatment. Active Case Finding and Contact Tracing: Research has shown that actively searching for TB cases among contacts of people with active TB increases the detection of secondary cases. Interventions at the primary health-care or community level can improve case detection, particularly in low- and moderate-incidence settings. Household and congregate-environment contact tracing strategies are especially effective. </extrainfo>